We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

28 hedge funds and large institutions have $5.6M invested in OSR Health Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $5.51M → $5.6M (+$86.4K)

10% less funds holding

Funds holding: 3128 (-3)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
4
Closed
4
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$1K

OSRHW Hedge Fund Activity: Q1 2024 in Review

28 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q1 2024, worth a combined $5.6M — up 1.6% from $5.51M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of OSRHW and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Bulldog Investors, opening a new position worth an estimated $334. The largest seller was Spartan Fund Management, exiting entirely with an estimated $3.84K sold.

  • 28 institutional investors held OSR Health Warrant (OSRHW) as of Q1 2024, down from 31 in Q4 2023.
  • Funds reported $5.6M of OSR Health Warrant stock for Q1 2024, up 1.6% quarter-over-quarter.
  • 2 funds opened new OSR Health Warrant positions in Q1 2024 and 4 closed out, a net change of -2 holders.
  • The largest OSR Health Warrant buyer in Q1 2024 was Bulldog Investors, an estimated $334 added.
  • The largest OSR Health Warrant seller in Q1 2024 was Spartan Fund Management, an estimated $3.84K sold.

Based on aggregated 13F filings for Q1 2024.